Regarding pricing, from what Absolut told me, it is priced according to the fact that it's not the most technologically advanced tool. For NSG, for sourcing and contracts, I think they pay in the hundreds of thousands a year, maybe two or three hundred thousand pounds, but I'm not certain on that.
Salesforce is priced at a premium, which poses challenges for acquiring it. Small and medium enterprises struggle with the high pricing. I suggest introducing pricing variations based on specific features required by smaller enterprises and adjusting prices to match the economic conditions of different regions.
SAP must reduce the pricing for Ariba. The solution is subscription-based. We pay annually for the tool. The license is expensive. It depends on how many users will be working on the platform.
SAP Ariba Procurement, is a cloud-based deployment, has an intuitive receipt and reconciliation processes and approvals can be done via mobiles. SAP Ariba Procurement has the following supporting softwares: SAP Ariba Buying and Invoicing, SAP Ariba Buying Solution and SAP Ariba Catalog Solution. They help manage suppliers, processes, budgets, approvals, and payments on a global basis. A unique software-as-a-service (SaaS) solutions, that ensure control and compliance between vendors,...
Regarding pricing, from what Absolut told me, it is priced according to the fact that it's not the most technologically advanced tool. For NSG, for sourcing and contracts, I think they pay in the hundreds of thousands a year, maybe two or three hundred thousand pounds, but I'm not certain on that.
Salesforce is priced at a premium, which poses challenges for acquiring it. Small and medium enterprises struggle with the high pricing. I suggest introducing pricing variations based on specific features required by smaller enterprises and adjusting prices to match the economic conditions of different regions.
There are cheaper options available. The licensing cost depends on the customer.
SAP must reduce the pricing for Ariba. The solution is subscription-based. We pay annually for the tool. The license is expensive. It depends on how many users will be working on the platform.
It is an expensive solution.